A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities
A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities
Recruiting · NCT07394374 · Registry updated 2026-02-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities | NTRK; NTRK Fusion Positive; NTRK Gene Fusion; Solid Tumors Harboring NTRK Fusion | Recruiting | Phase 1 / Phase 2 | 2026-02-06 | NCT07394374 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cullgen (Shanghai),Inc | 2 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanxi Provincial Cancer Hospital | Taiyuan | China | 16 |
| Sun Yat-sen Memorial Hospital, Sun Yat-sen University | Guangzhou | China | 24 |
| The Cancer Hospital, Chinese Academy of Medical Sciences | Beijing | China | 1 |
| The Sir Run Run Shaw Hospital, Affiliated to Zhejiang University School of Medicine | Hangzhou | China | 1 |
| West China Hospital of Sichuan University | Chengdu | China | 30 |
| Zhejiang Provincial Cancer Hospital | Hangzhou | China | 2 |